Back to News
Market Impact: 0.18
Sunshine Biopharma Expands Oncology Support Portfolio With Generic Zofran Launch In Canada
Source: Nasdaq
Healthcare & BiotechProduct Launches
Sunshine Biopharma launched generic Ondansetron tablets in Canada, expanding its oncology supportive-care portfolio. The product launch modestly broadens the company's generic prescription-medicine offering, though no sales outlook or financial impact was disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
SBFM0.55
More News
- Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
- Musk says Tesla will refund some Cybertruck deposits, defends decision to end production
- Bon Secours affiliate sweetens bid for Surgery Partners to up to $6 billion
- CorMedix stock gains as Heron deal adds four products
- Rezolute at Guggenheim: FDA progress lifts rare-disease hopes
- Hims & Hers earnings up next: Can GLP-1 boom drive profit?